{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:52:56Z","timestamp":1790434376460,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI095436"],"award-info":[{"award-number":["R01 AI095436"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI153209"],"award-info":[{"award-number":["R01 AI153209"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI164653"],"award-info":[{"award-number":["R01 AI164653"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI049820"],"award-info":[{"award-number":["T32 AI049820"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UC7AI180311"],"award-info":[{"award-number":["UC7AI180311"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"United States Department of Defense | Defense Threat Reduction Agency","doi-asserted-by":"publisher","award":["MCDC 2103-011"],"award-info":[{"award-number":["MCDC 2103-011"]}],"id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62513-3","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:26:20Z","timestamp":1754425580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Three positively charged binding sites on the eastern equine encephalitis virus E2 glycoprotein coordinate heparan sulfate- and protein receptor-dependent infection"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-3647","authenticated-orcid":false,"given":"Maria D. H.","family":"Alcorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Theron C.","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana","family":"Lukash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Crasto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8016-8556","authenticated-orcid":false,"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4506-7842","authenticated-orcid":false,"given":"William B.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"62513_CR1","unstructured":"Griffin, D. E. & Weaver, S. C. Alphaviruses in Fields Virology Volume 1 Emerging Viruses Vol. 1 (eds. Howley, P. M. and Knipe, D. M.) 194\u2013244 (Philadelphia, PA Lippincott Williams & Wilkins, 2021)."},{"key":"62513_CR2","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1128\/JVI.01323-08","volume":"82","author":"CL Gardner","year":"2008","unstructured":"Gardner, C. L. et al. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J. Virol. 82, 10634\u201310646 (2008).","journal-title":"J. Virol."},{"key":"62513_CR3","doi-asserted-by":"publisher","first-page":"16026","DOI":"10.1073\/pnas.1110617108","volume":"108","author":"CL Gardner","year":"2011","unstructured":"Gardner, C. L., Ebel, G. D., Ryman, K. D. & Klimstra, W. B. Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Proc. Natl. Acad. Sci. USA 108, 16026\u201316031 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62513_CR4","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.1128\/JVI.00937-13","volume":"87","author":"CL Gardner","year":"2013","unstructured":"Gardner, C. L. et al. Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in mice. J. Virol. 87, 8582\u20138590 (2013).","journal-title":"J. Virol."},{"key":"62513_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12869","volume":"506","author":"DW Trobaugh","year":"2014","unstructured":"Trobaugh, D. W. et al. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506, 245\u2013248 (2014).","journal-title":"Nature"},{"key":"62513_CR6","doi-asserted-by":"publisher","first-page":"e1007584","DOI":"10.1371\/journal.ppat.1007584","volume":"15","author":"DW Trobaugh","year":"2019","unstructured":"Trobaugh, D. W., Sun, C., Dunn, M. D., Reed, D. S. & Klimstra, W. B. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants. PLoS Pathog. 15, e1007584 (2019).","journal-title":"PLoS Pathog."},{"key":"62513_CR7","doi-asserted-by":"publisher","unstructured":"Alcorn, M. D. H. & Klimstra, W. B. Glycosaminoglycan binding by arboviruses: a cautionary tale. J. Gen. Virol. 103, https:\/\/doi.org\/10.1099\/jgv.0.001726 (2022).","DOI":"10.1099\/jgv.0.001726"},{"key":"62513_CR8","doi-asserted-by":"publisher","first-page":"8890","DOI":"10.1073\/pnas.1910670117","volume":"117","author":"CL Chen","year":"2020","unstructured":"Chen, C. L. et al. Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues. Proc. Natl. Acad. Sci. USA 117, 8890\u20138899 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62513_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-021-04326-0","volume":"602","author":"LE Clark","year":"2022","unstructured":"Clark, L. E. et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature 602, 475\u2013480 (2022).","journal-title":"Nature"},{"key":"62513_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44624-x","volume":"15","author":"H Ma","year":"2024","unstructured":"Ma, H. et al. The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses. Nat. Commun. 15, 246 (2024).","journal-title":"Nat. Commun."},{"key":"62513_CR11","doi-asserted-by":"publisher","unstructured":"Adams, L. J. et al. Structural and functional basis of VLDLR usage by eastern equine encephalitis virus. Cell https:\/\/doi.org\/10.1016\/j.cell.2023.11.031 (2024).","DOI":"10.1016\/j.cell.2023.11.031"},{"key":"62513_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50887-9","volume":"15","author":"P Yang","year":"2024","unstructured":"Yang, P. et al. Structural basis for VLDLR recognition by eastern equine encephalitis virus. Nat. Commun. 15, 6548 (2024).","journal-title":"Nat. Commun."},{"key":"62513_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51293-x","volume":"15","author":"D Cao","year":"2024","unstructured":"Cao, D. et al. The receptor VLDLR binds eastern equine encephalitis virus through multiple distinct modes. Nat. Commun. 15, 6866 (2024).","journal-title":"Nat. Commun."},{"key":"62513_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.pharmthera.2009.05.001","volume":"123","author":"M Rusnati","year":"2009","unstructured":"Rusnati, M. et al. Sulfated K5 Escherichia coli polysaccharide derivatives: a novel class of candidate antiviral microbicides. Pharmacol. Ther. 123, 310\u2013322 (2009).","journal-title":"Pharmacol. Ther."},{"key":"62513_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1462-5822.2004.00389.x","volume":"6","author":"PG Spear","year":"2004","unstructured":"Spear, P. G. Herpes simplex virus: receptors and ligands for cell entry. Cell. Microbiol. 6, 401\u2013410 (2004).","journal-title":"Cell. Microbiol."},{"key":"62513_CR16","doi-asserted-by":"publisher","first-page":"12714","DOI":"10.1128\/JVI.00717-09","volume":"83","author":"M Kalia","year":"2009","unstructured":"Kalia, M., Chandra, V., Rahman, S. A., Sehgal, D. & Jameel, S. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83, 12714\u201312724 (2009).","journal-title":"J. Virol."},{"key":"62513_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1006\/viro.2000.0241","volume":"270","author":"JF Aronson","year":"2000","unstructured":"Aronson, J. F. et al. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus. Virology 270, 111\u2013123 (2000).","journal-title":"Virology"},{"key":"62513_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/viro.2000.0546","volume":"276","author":"KA Bernard","year":"2000","unstructured":"Bernard, K. A., Klimstra, W. B. & Johnston, R. E. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276, 93\u2013103 (2000).","journal-title":"Virology"},{"key":"62513_CR19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41586-020-2915-3","volume":"588","author":"H Ma","year":"2020","unstructured":"Ma, H. et al. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Nature 588, 308\u2013314 (2020).","journal-title":"Nature"},{"key":"62513_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-018-0286-4","volume":"4","author":"AS Kim","year":"2019","unstructured":"Kim, A. S. et al. Protective antibodies against eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Nat. Microbiol. 4, 187\u2013197 (2019).","journal-title":"Nat. Microbiol."},{"key":"62513_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/iai.65.1.1-8.1997","volume":"65","author":"KS Rostand","year":"1997","unstructured":"Rostand, K. S. & Esko, J. D. Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1\u20138 (1997).","journal-title":"Infect. Immun."},{"key":"62513_CR22","doi-asserted-by":"publisher","first-page":"e2719","DOI":"10.1371\/journal.pntd.0002719","volume":"8","author":"CL Gardner","year":"2014","unstructured":"Gardner, C. L. et al. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl. Trop. Dis. 8, e2719 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"62513_CR23","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1128\/JVI.72.9.7349-7356.1998","volume":"72","author":"AP Byrnes","year":"1998","unstructured":"Byrnes, A. P. & Griffin, D. E. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72, 7349\u20137356 (1998).","journal-title":"J. Virol."},{"key":"62513_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","volume":"83","author":"D Xu","year":"2014","unstructured":"Xu, D. & Esko, J. D. Demystifying heparan sulfate-protein interactions. Annu. Rev. Biochem. 83, 129\u2013157 (2014).","journal-title":"Annu. Rev. Biochem."},{"key":"62513_CR25","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1128\/JVI.02494-06","volume":"81","author":"KD Ryman","year":"2007","unstructured":"Ryman, K. D. et al. Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J. Virol. 81, 3563\u20133573 (2007).","journal-title":"J. Virol."},{"key":"62513_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biochi.2022.03.011","volume":"198","author":"A Boyce","year":"2022","unstructured":"Boyce, A. & Walsh, G. Production, characteristics and applications of microbial heparinases. Biochimie 198, 109\u2013140 (2022).","journal-title":"Biochimie"},{"key":"62513_CR27","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.1039\/C7OB01058C","volume":"15","author":"RJ Weiss","year":"2017","unstructured":"Weiss, R. J., Esko, J. D. & Tor, Y. Targeting heparin and heparan sulfate protein interactions. Org. Biomol. Chem. 15, 5656\u20135668 (2017).","journal-title":"Org. Biomol. Chem."},{"key":"62513_CR28","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1128\/JVI.72.9.7357-7366.1998","volume":"72","author":"WB Klimstra","year":"1998","unstructured":"Klimstra, W. B., Ryman, K. D. & Johnston, R. E. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72, 7357\u20137366 (1998).","journal-title":"J. Virol."},{"key":"62513_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.cell.2019.04.006","volume":"177","author":"K Basore","year":"2019","unstructured":"Basore, K. et al. Cryo-EM structure of chikungunya virus in complex with the Mxra8 receptor. Cell 177, 1725\u20131737.e1716 (2019).","journal-title":"Cell"},{"key":"62513_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-021-03963-9","volume":"598","author":"K Basore","year":"2021","unstructured":"Basore, K. et al. Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor. Nature 598, 672\u2013676 (2021).","journal-title":"Nature"},{"key":"62513_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41586-021-03909-1","volume":"598","author":"B Ma","year":"2021","unstructured":"Ma, B., Huang, C., Ma, J., Xiang, Y. & Zhang, X. Structure of Venezuelan equine encephalitis virus with its receptor LDLRAD3. Nature 598, 677\u2013681 (2021).","journal-title":"Nature"},{"key":"62513_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570\u2013574 (2018).","journal-title":"Nature"},{"key":"62513_CR33","doi-asserted-by":"publisher","unstructured":"Zimmerman, O. et al. Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8. Cell https:\/\/doi.org\/10.1016\/j.cell.2023.09.007 (2023).","DOI":"10.1016\/j.cell.2023.09.007"},{"key":"62513_CR34","doi-asserted-by":"publisher","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","volume":"25","author":"E Wang","year":"2007","unstructured":"Wang, E. et al. Chimeric Sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine 25, 7573\u20137581 (2007).","journal-title":"Vaccine"},{"key":"62513_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1126\/science.1321985","volume":"257","author":"CJ Mitchell","year":"1992","unstructured":"Mitchell, C. J. et al. Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida. Science 257, 526\u2013527 (1992).","journal-title":"Science"},{"key":"62513_CR36","doi-asserted-by":"publisher","unstructured":"Pereira-Dos-Santos, T., Roiz, D., Louren\u00e7o-de-Oliveira, R. & Paupy, C. A systematic review: is. Pathogens 9, https:\/\/doi.org\/10.3390\/pathogens9040266 (2020).","DOI":"10.3390\/pathogens9040266"},{"key":"62513_CR37","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.62.5.687","volume":"62","author":"MH Merrill","year":"1935","unstructured":"Merrill, M. H. & Tenbroeck, C. The transmission of equine encephalomyelitis virus by Aedes aegypti. J. Exp. Med. 62, 687\u2013695 (1935).","journal-title":"J. Exp. Med."},{"key":"62513_CR38","first-page":"364","volume":"26","author":"WE Collins","year":"1966","unstructured":"Collins, W. E., Harrison, A. J. & Jumper, J. R. Transmission of eastern equine encephalitis virus by Aedes aegypti infected by larval exposure and membrane feeding. Mosq. N. 26, 364\u2013367 (1966).","journal-title":"Mosq. N."},{"key":"62513_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1128\/JVI.74.2.644-651.2000","volume":"74","author":"AP Byrnes","year":"2000","unstructured":"Byrnes, A. P. & Griffin, D. E. Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J. Virol. 74, 644\u2013651 (2000).","journal-title":"J. Virol."},{"key":"62513_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae119","volume":"3","author":"SE Ander","year":"2024","unstructured":"Ander, S. E. et al. Phagocyte-expressed glycosaminoglycans promote capture of alphaviruses from the blood circulation in a host species-specific manner. PNAS Nexus 3, pgae119 (2024).","journal-title":"PNAS Nexus"},{"key":"62513_CR41","doi-asserted-by":"publisher","first-page":"8909","DOI":"10.1128\/JVI.78.16.8909-8916.2004","volume":"78","author":"HV Reddi","year":"2004","unstructured":"Reddi, H. V. et al. Heparan sulfate-independent infection attenuates high-neurovirulence GDVII virus-induced encephalitis. J. Virol. 78, 8909\u20138916 (2004).","journal-title":"J. Virol."},{"key":"62513_CR42","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1016\/j.cell.2021.09.001","volume":"184","author":"SS Ganaie","year":"2021","unstructured":"Ganaie, S. S. et al. Lrp1 is a host entry factor for Rift Valley fever virus. Cell 184, 5163\u20135178.e5124 (2021).","journal-title":"Cell"},{"key":"62513_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204706119","volume":"119","author":"MM Schwarz","year":"2022","unstructured":"Schwarz, M. M. et al. Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. Proc. Natl. Acad. Sci. USA 119, e2204706119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62513_CR44","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein, D., Werman, A., Novick, D., Barak, S. & Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 110, 7306\u20137311 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62513_CR45","doi-asserted-by":"publisher","unstructured":"Zimmerman, O., Holmes, A. C., Kafai, N. M., Adams, L. J. & Diamond, M. S. Entry receptors - the gateway to alphavirus infection. J. Clin. Invest. 133, https:\/\/doi.org\/10.1172\/JCI165307 (2023).","DOI":"10.1172\/JCI165307"},{"key":"62513_CR46","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1128\/JVI.02514-07","volume":"82","author":"PV Aguilar","year":"2008","unstructured":"Aguilar, P. V. et al. Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence. J. Virol. 82, 4920\u20134930 (2008).","journal-title":"J. Virol."},{"key":"62513_CR47","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1128\/JVI.02990-13","volume":"88","author":"C Sun","year":"2014","unstructured":"Sun, C., Gardner, C. L., Watson, A. M., Ryman, K. D. & Klimstra, W. B. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J. Virol. 88, 2035\u20132046 (2014).","journal-title":"J. Virol."},{"key":"62513_CR48","doi-asserted-by":"publisher","unstructured":"Brown, A. J., Gibson, S., Hatton, D. & James, D. C. Transcriptome-Based Identification Of The Optimal Reference CHO genes for normalisation of qPCR data. Biotechnol. J. 13, https:\/\/doi.org\/10.1002\/biot.201700259 (2018).","DOI":"10.1002\/biot.201700259"},{"key":"62513_CR49","doi-asserted-by":"publisher","unstructured":"Syedbasha, M. et al. An ELISA based binding and competition method to rapidly determine ligand-receptor interactions. J. Vis. Exp. https:\/\/doi.org\/10.3791\/53575 (2016).","DOI":"10.3791\/53575"},{"key":"62513_CR50","doi-asserted-by":"publisher","first-page":"11344","DOI":"10.1073\/pnas.0402905101","volume":"101","author":"AC Brault","year":"2004","unstructured":"Brault, A. C. et al. Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc. Natl. Acad. Sci. USA 101, 11344\u201311349 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62513_CR51","doi-asserted-by":"publisher","unstructured":"Gardner, C. L. et al. Antibody preparations from human transchromosomic cows exhibit prophylactic and therapeutic efficacy against Venezuelan equine encephalitis virus. J. Virol. 91, https:\/\/doi.org\/10.1128\/JVI.00226-17 (2017).","DOI":"10.1128\/JVI.00226-17"},{"key":"62513_CR52","doi-asserted-by":"publisher","first-page":"e1009308","DOI":"10.1371\/journal.ppat.1009308","volume":"17","author":"JR Albe","year":"2021","unstructured":"Albe, J. R. et al. Physiological and immunological changes in the brain associated with lethal eastern equine encephalitis virus in macaques. PLoS Pathog. 17, e1009308 (2021).","journal-title":"PLoS Pathog."},{"key":"62513_CR53","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"62513_CR54","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62513-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62513-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:22:05Z","timestamp":1757344925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62513-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62513"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62513-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.04.621500","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.B.K. is a co-founder of Advanced Virology. M.S.D. is a consultant or advisor for Inbios, Vir Biotechnology, IntegerBio, Moderna, Merck Sharp & Dohme Corporation, and GlaxoSmithKline. The Diamond laboratory has received additional unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, and IntegerBio. S.C.W. is a consultant for Valneva. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7227"}}